Nanosonics WKN: A0MQVE ISIN: AU000000NAN9 Kürzel: OQS Branche: Gesundheit, Medizinische, Instrumente, Zubehör
|
Themen zum Wert | ||
---|---|---|---|
1 | Nanosonics |
Kursdetails
Geld (bid) | 1,630 (301) |
---|---|
Brief (ask/offer) | 1,700 (301) |
Spread | 4,118 |
Geh. Stück | 0 |
Eröffnung | 1,665 |
Vortag | 1,665 |
Tageshoch | 1,665 |
Tagestief | 1,650 |
52W Hoch | 3,450 |
52W Tief | 1,595 |
Tagesvolumen
in EUR gehandelt | 0 Stk |
---|---|
in USD gehandelt | 11.407 Stk |
in CHF gehandelt | 0 Stk |
in AUD gehandelt | 0 Stk |
Gesamt | 11.407 Stk |
Partner-News
Anzeige15:00 Uhr • Partner • Societe Generale
7:01 Uhr • Partner • Societe Generale
Gestern 18:00 Uhr • Partner • Societe Generale
Gestern 16:46 Uhr • Partner • Societe Generale
Gestern 16:00 Uhr • Partner • BNP Paribas
Aktien-News
15:14 Uhr • Artikel • dpa-AFX
14:14 Uhr • Meldungen • EQS News
13:29 Uhr • Artikel • dpa-AFX
13:17 Uhr • Artikel • dpa-AFX
13:15 Uhr • Artikel • dpa-AFX
Geld/Brief Kurse
Neu ladenBörse | Geld | Vol. | Brief | Vol. | Zeit | Vol. ges. | Kurs |
---|---|---|---|---|---|---|---|
L&S Exchange | 1,630 | 301 Stk | 1,700 | 301 Stk | 1711663184 28. Mar | 1,665 EUR | |
Nasdaq OTC | 1710375000 14. Mar | 11.407 Stk | 1,870 USD | ||||
Frankfurt | 1,620 | 3.168 Stk | 1,700 | 3.018 Stk | 1711609547 28. Mar | 1,620 EUR | |
Lang & Schwarz | 1,630 | 301 Stk | 1,700 | 301 Stk | 1711663172 28. Mar | 1,665 EUR | |
Berlin | 1,620 | 3.168 Stk | 1,700 | 3.018 Stk | 1711610175 28. Mar | 1,610 EUR | |
Düsseldorf | 1,620 | 4.000 Stk | 1,710 | 4.000 Stk | 1711650650 28. Mar | 1,620 EUR | |
Stuttgart | 1,630 | 8.000 Stk | 1,700 | 8.000 Stk | 1711618473 28. Mar | 1,620 EUR | |
BX Swiss | 1,586 | 12.877 Stk | 1,655 | 12.877 Stk | 1711556988 27. Mar | 1,587 CHF | |
Sydney | 1711431311 26. Mar | 2,710 AUD | ges. 11.407 Stk |
Börsennotierung
Marktkapitalisierung in EUR |
---|
503,3 Mio. |
Anzahl der Aktien |
302,3 Mio. |
Termine
17.04.2024 | Quartalsmitteilung |
---|---|
31.07.2024 | Quartalsmitteilung |
02/25 | Quartalsmitteilung |
Grundlegende Daten zur NANOSONICS Aktie
Finanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
---|---|---|---|---|---|---|---|
KUV | 10,24 | 22,43 | 8,52 | 8,41 | - | - | - |
Ergebnis je Aktie (bereinigt) | 0,07 | 0,02 | 0,01 | 0,07 | 0,03 | - | - |
Cashflow | 22,8 Mio. | 7,3 Mio. | 6,7 Mio. | 23,3 Mio. | - | - | - |
Eigenkapitalquote | 83,81 % | 82,37 % | 71,77 % | 72,48 % | - | - | - |
Verschuldungsgrad | 19,32 | 21,40 | 39,33 | 37,97 | - | - | - |
EBIT | 11,7 Mio. | 8,4 Mio. | 792 Tsd. | 18,0 Mio. | - | - | - |
Fundamentaldaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
KCV | 43,54 | 291,65 | 166,10 | 57,82 | - | - | - |
Kurs-Gewinn-Verhältnis (KGV) | 99,51 | 291,65 | 332,19 | 66,08 | 95,40 | - | - |
Bilanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
Umsatzerlöse | 99,4 Mio. | 101,8 Mio. | 119,7 Mio. | 167,5 Mio. | - | - | - |
Ergebnis vor Steuern | 12,5 Mio. | 11,0 Mio. | 1,6 Mio. | 21,6 Mio. | - | - | - |
Steuern | 2,3 Mio. | 2,4 Mio. | -2,2 Mio. | 1,7 Mio. | - | - | - |
Info NANOSONICS Aktie
Nanosonics
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.